Viewing Study NCT00528333


Ignite Creation Date: 2025-12-25 @ 2:47 AM
Ignite Modification Date: 2026-01-08 @ 12:26 PM
Study NCT ID: NCT00528333
Status: COMPLETED
Last Update Posted: 2015-01-07
First Post: 2007-09-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Lintuzumab (SGN-33) in Combination With Low Dose Cytarabine in Patients 60+ Years With AML
Sponsor: Seagen Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module